Business
Why the CSL (ASX:CSL) share price has rebounded 13% since March
The CSL Limited (ASX: CSL) share price has been rebounding lately after hitting a 52-week low of $242.00 on 9 March. Since then, the company has gained 12.95%, with CSL shares currently trading at $273.35.
The global biotech has been busy producing the AstraZeneca COVID-19 vaccine while attempting to combat plasma collection concerns. Could this be the catalyst for its recent share price rise?
What’s driving the CSL share price higher?
Investors appear upbeat about the company’s progress to address its current issues as well as its attempts to open up new opportunities.
As announced on 14 April, CSL has been focused on increasing its plasma-protein production through its launch of a global challenge. The company is inviting…
-
Business13 hours agoWarning! These ASX 200 shares were just downgraded
-
Business11 hours ago2 monthly payers you’ll want to own in 2025 and beyond
-
Noosa News6 hours agoVegetables and herbs you can easily and cheaply grow from seeds
-
General22 hours agoTelco Exetel fined $694K after scammers bypass verification processes, access bank accounts